194 related articles for article (PubMed ID: 9302744)
1. Hepatitis B vaccine in hemodialysis patients with hepatitis C viral infection.
Cheng CH; Huang CC; Leu ML; Chiang CY; Wu MS; Lai PC
Vaccine; 1997; 15(12-13):1353-7. PubMed ID: 9302744
[TBL] [Abstract][Full Text] [Related]
2. Factors affecting responsiveness to hepatitis B immunization in dialysis patients.
Asan A; Demirhan H; Sorkun HÇ; Özkan S; Aydın M; Akın D; Tatar B; Çatak B; Şener A; Köse Ş
Int Urol Nephrol; 2017 Oct; 49(10):1845-1850. PubMed ID: 28620716
[TBL] [Abstract][Full Text] [Related]
3. [Prevalence of response to anti-HBV infection in patients on maintenance hemodialysis infected with hepatitis C virus (HCV)].
Muszytowski M; Manitius J; Ruszkiewicz-Fołda M
Przegl Lek; 1996; 53(5):417-9. PubMed ID: 8754404
[TBL] [Abstract][Full Text] [Related]
4. Significance and anamnestic response in isolated hepatitis B core antibody-positive individuals 18 years after neonatal hepatitis B virus vaccination in Taiwan.
Su FH; Bai CH; Chu FY; Lin YS; Su CT; Yeh CC
Vaccine; 2012 Jun; 30(27):4034-9. PubMed ID: 22531558
[TBL] [Abstract][Full Text] [Related]
5. The evaluation of immune responses that occur after HBV infection and HBV vaccination in hemodialysis patients.
Kara IH; Yilmaz ME; Suner A; Kadiroglu AK; Isikoglu B
Vaccine; 2004 Sep; 22(29-30):3963-7. PubMed ID: 15364445
[TBL] [Abstract][Full Text] [Related]
6. HBV and HCV infection in Japanese dental care workers.
Nagao Y; Matsuoka H; Kawaguchi T; Ide T; Sata M
Int J Mol Med; 2008 Jun; 21(6):791-9. PubMed ID: 18506374
[TBL] [Abstract][Full Text] [Related]
7. Antibody level after hepatitis B vaccination in hemodialysis patients: influence of hepatitis C virus infection.
Navarro JF; Teruel JL; Mateos ML; Marcen R; Ortuno J
Am J Nephrol; 1996; 16(2):95-7. PubMed ID: 8919223
[TBL] [Abstract][Full Text] [Related]
8. Loss of hepatitis B immunity in hemodialysis patients acquired either naturally or after vaccination.
Tsouchnikas I; Dounousi E; Xanthopoulou K; Papakonstantinou S; Thomoglou V; Tsakiris D
Clin Nephrol; 2007 Oct; 68(4):228-34. PubMed ID: 17969490
[TBL] [Abstract][Full Text] [Related]
9. Prevalence of hepatitis B virus infection among health care workers in a tertiary hospital in Tanzania.
Mueller A; Stoetter L; Kalluvya S; Stich A; Majinge C; Weissbrich B; Kasang C
BMC Infect Dis; 2015 Sep; 15():386. PubMed ID: 26399765
[TBL] [Abstract][Full Text] [Related]
10. Levamisole treatment enhances protective antibody response to hepatitis B vaccination in hemodialysis patients.
Kayataş M
Artif Organs; 2002 Jun; 26(6):492-6. PubMed ID: 12072104
[TBL] [Abstract][Full Text] [Related]
11. Vaccination against hepatitis B: results of the analysis of 2000 population members in Croatia.
Palmović D; Crnjaković-Palmović J
Eur J Epidemiol; 1994 Oct; 10(5):541-7. PubMed ID: 7859852
[TBL] [Abstract][Full Text] [Related]
12. [Investigation of hemodialysis patients in terms of the presence of occult hepatitis B].
Altindiş M; Uslan I; Cetinkaya Z; Yüksel S; Ciftçi IH; Demirtürk N; Ozdemir M; Arslan F; Aktepe OC
Mikrobiyol Bul; 2007 Apr; 41(2):227-33. PubMed ID: 17682709
[TBL] [Abstract][Full Text] [Related]
13. Comparative immunogenicity of 2 recombinant hepatitis B vaccines (GeneVac-B and Engerix-B) in adult patients with chronic renal failure.
Rajapurkar MM; Gang S; Dabhi M; Kulkarni PS
J Nephrol; 2007; 20(5):596-601. PubMed ID: 17918146
[TBL] [Abstract][Full Text] [Related]
14. High-titer antibody to hepatitis B surface antigen before liver transplantation can prevent de novo hepatitis B infection.
Su WJ; Ho MC; Ni YH; Chen HL; Hu RH; Wu YM; Chang MH; Lee PH
J Pediatr Gastroenterol Nutr; 2009 Feb; 48(2):203-8. PubMed ID: 19179883
[TBL] [Abstract][Full Text] [Related]
15. Factors affecting inadequate response to HBV vaccine in hemodialysis patients: northeast anatolia survey with six hemodialysis centers.
Erdoğdu Hİ; Atalay E; Gürsoy G; Canbakan B; Aktürk S; Yazıcı C; Yücel O; Mersin S; Üçer S; Merhametsiz Ö; Öner C; Erat M
Clin Exp Nephrol; 2019 Apr; 23(4):530-536. PubMed ID: 30488288
[TBL] [Abstract][Full Text] [Related]
16. Intradermal vaccination of adults with three low doses (2 micrograms) of recombinant hepatitis B vaccine. II. Persistence of immunity and induction of immunologic memory.
Elisbão Mdo C; Baldy JL; Bonametti AM; Reiche EM; Morimoto HK; Pontello R; Matsuo T; Ferelle A; Neves J
Mem Inst Oswaldo Cruz; 2003 Dec; 98(8):1109-13. PubMed ID: 15049099
[TBL] [Abstract][Full Text] [Related]
17. HBV vaccination of HCV-infected patients with occult HBV infection and anti-HBc-positive blood donors.
Pereira JS; Gonçales NS; Silva C; Lazarini MS; Pavan MH; Fais VC; Gonçales Júnior FL
Braz J Med Biol Res; 2006 Apr; 39(4):525-31. PubMed ID: 16612476
[TBL] [Abstract][Full Text] [Related]
18. Low levels of awareness, vaccine coverage, and the need for boosters among health care workers in tertiary care hospitals in India.
Sukriti ; Pati NT; Sethi A; Agrawal K; Agrawal K; Kumar GT; Kumar M; Kaanan AT; Sarin SK
J Gastroenterol Hepatol; 2008 Nov; 23(11):1710-5. PubMed ID: 18761556
[TBL] [Abstract][Full Text] [Related]
19. [Anti-HBs persistence following primary vaccination with three doses of hepatitis B vaccine among normal and high-responder adults: a 3-year follow-up study].
Lyu JJ; Zhang L; Yan BY; Liu JY; Feng Y; Song LZ; Chen SY; Zhou LB; Liang XF; Cui FQ; Wang FZ; Xu AQ
Zhonghua Yu Fang Yi Xue Za Zhi; 2016 Jun; 50(6):478-83. PubMed ID: 27256725
[TBL] [Abstract][Full Text] [Related]
20. Response to single dose hepatitis B vaccine in Congolese non-HIV hemodialysis patients: a prospective observational study.
Kengibe PY; Makulo JR; Nlandu YM; Lepira FB; Sumaili EK; Bukabau JB; Mbendi CN; Ahuka SM; Tshimpi AW; Ngoma PK; Mangani NN; Mbendi SN
Pan Afr Med J; 2019; 34():122. PubMed ID: 33708291
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
